Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: A randomised, placebo-controlled, phase 3 trial

Sandra V. Navarra, Renato M. Guzmán, Alberto E. Gallacher, Stephen Hall, Roger A. Levy, Renato E. Jimenez, Edmund K.M. Li, Mathew Thomas, Ho Youn Kim, Manuel G. León, Coman Tanasescu, Eugeny Nasonov, Joung Liang Lan, Lilia Pineda, Z. John Zhong, William Freimuth, Michelle A. Petri

Research output: Contribution to journalArticlepeer-review

1110 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: A randomised, placebo-controlled, phase 3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences